Rasmus Holm Jorgensen
About Rasmus Holm Jorgensen
Rasmus Holm-Jorgensen Company Overview
Rasmus Holm-Jorgensen is the Chief Financial Officer with a deep background in building companies and driving strategy. With over 25 years of experience, he has played crucial roles in various leading pharmaceutical companies, contributing significantly to their growth and success.
Rasmus Holm-Jorgensen Career Achievements
Rasmus Holm-Jorgensen was part of the founding team of Kiniksa Pharmaceuticals, where he led the company through its IPO and product launch. He notably expanded Synageva BioPharma's portfolio as Group VP and General Manager, which led to the company’s sale for $9 billion. Additionally, he has worked for 12 years at Novo Nordisk, handling responsibilities across different regions including the U.S., Europe, and LATAM in roles related to economy and planning, portfolio analysis, investor relations, and finance.
Rasmus Holm-Jorgensen Education and Expertise
Rasmus holds an M.S. in Economics from Copenhagen University. He has further enriched his education with executive training at prestigious institutions such as INSEAD, Stanford University, and Harvard Business School. His expertise is deeply rooted in the pharmaceutical industry, with extensive experience in finance, strategy development, and operational leadership.
Rasmus Holm-Jorgensen Background and Experience
Rasmus Holm-Jorgensen boasts over 25 years of experience in the pharmaceutical sector. His career includes significant roles at Novo Nordisk, where he was responsible for economy and planning, portfolio analysis, investor relations, and finance across multiple continents. His extensive background also includes strategic leadership roles in launching and expanding high-value portfolios in the biotechnology space.